Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-09-18 to 2023-09-19
Current total value of award: $25.08
Description: 4562208980!INSULIN HUMAN INJECTION MODIFIED 100 USP